Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05839678
Other study ID # 2022-3413
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2022
Est. completion date December 1, 2024

Study information

Verified date April 2023
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Multicenter trial about anterior mediastinal cysts


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: cysts in the anterior mediastinum - Thymic cysts - Bronchogenic cysts - Pericardial cysts - Cystic thymoma - Cystic teratoma Exclusion Criteria: - Patients <18 years old - Patients without radiological imaging - Patients without approval for follow-up

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Maastricht UMC Maastricht Limburg

Sponsors (3)

Lead Sponsor Collaborator
Maastricht University Medical Center Erasmus Medical Center, The Netherlands Cancer Institute

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage correctly diagnosed cystic laesions 2000-2022
Secondary Patient characteristics, complications, comborbidities 2000-2022
See also
  Status Clinical Trial Phase
Completed NCT00280514 - Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Phase 4
Completed NCT01087060 - Detection of Renal Malignancy of Complicated Renal Cysts N/A
Completed NCT00001912 - Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis N/A